|
HAUS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.969800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.269600E-01 |
| Normal-vs-Stage2 |
9.087800E-01 |
| Normal-vs-Stage3 |
3.717900E-03 |
| Normal-vs-Stage4 |
3.959900E-02 |
| Stage1-vs-Stage2 |
4.907800E-01 |
| Stage1-vs-Stage3 |
3.07180000003182E-06 |
| Stage1-vs-Stage4 |
1.401970E-03 |
| Stage2-vs-Stage3 |
2.091700E-02 |
| Stage2-vs-Stage4 |
1.117350E-01 |
| Stage3-vs-Stage4 |
5.252000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.152600E-01 |
| Normal-vs-AfricanAmerican |
2.007400E-01 |
| Normal-vs-Asian |
6.825600E-01 |
| Caucasian-vs-AfricanAmerican |
4.574800E-01 |
| Caucasian-vs-Asian |
5.126000E-01 |
| AfricanAmerican-vs-Asian |
3.661600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.148400E-01 |
| Normal-vs-Female |
6.460000E-01 |
| Male-vs-Female |
4.380400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.052200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.045800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.416000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.956200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.663600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.951000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.554800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.598200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.514400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.993200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.181800E-02 |
| Normal-vs-Grade 2 |
4.095600E-01 |
| Normal-vs-Grade 3 |
4.294000E-02 |
| Normal-vs-Grade 4 |
3.143200E-03 |
| Grade 1-vs-Grade 2 |
1.830020E-01 |
| Grade 1-vs-Grade 3 |
4.519800E-03 |
| Grade 1-vs-Grade 4 |
1.915940E-03 |
| Grade 2-vs-Grade 3 |
1.183560E-04 |
| Grade 2-vs-Grade 4 |
2.17529999999577E-05 |
| Grade 3-vs-Grade 4 |
9.332200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.300000E-02 |
| Normal-vs-ccB subtype |
2.023600E-02 |
| ccA subtype-vs-ccB subtype |
9.64520000534819E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.226000E-01 |
| Normal-vs-N1 |
1.693610E-01 |
| N0-vs-N1 |
3.977000E-01 |
|
|
